NCT00187681 Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects Status COMPLETED Phase PHASE4
NCT00184626 Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. Status COMPLETED Phase PHASE4
NCT00184574 Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00174642 Opposing Step-by-step Insulin Reinforcement to Intensified Strategy Status COMPLETED Phase PHASE3
NCT00169624 Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin Status TERMINATED Phase PHASE3
NCT00151411 Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS) Status COMPLETED Phase PHASE2
NCT00139477 Study of Serum Markers for Cardiovascular Risk in Obese Youth and Impact of Lifestyle and Medication Intervention Status COMPLETED Phase NA
NCT00134303 Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity Status COMPLETED Phase PHASE4
NCT00134290 The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance Status COMPLETED Phase PHASE4
NCT00131664 Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) Status COMPLETED Phase PHASE3
NCT00121966 South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00121641 Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT00118963 Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes Status COMPLETED Phase PHASE4
NCT00118950 Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet Status COMPLETED Phase PHASE4
NCT00118937 Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet Status COMPLETED Phase PHASE4
NCT00111631 A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00110851 Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) Status COMPLETED Phase PHASE2
NCT00108615 Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance Status COMPLETED Phase PHASE4